← Back to directory

Miquel Bernardo

Researcher Next ID · RN-035374

Researcher · Arts and Humanities

Instituto de Salud Carlos III

Madrid, Spain

Accepting doctoral researchersFunding unknown
Works count
733
Citation count
18,844
H-index
66
i10-index
366

Research interests

Arts and Humanities
Medicine
Neuroscience
Schizophrenia research and treatment
Bipolar Disorder and Treatment
Tryptophan and brain disorders
Mental Health and Psychiatry
Electroconvulsive Therapy Studies

Publications

  • Resilience and mental health during the COVID-19 pandemic

    Journal of Affective Disorders · 2021 · 10.1016/j.jad.2021.01.055

  • Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case–control study

    Psychological Medicine · 2020 · 10.1017/s003329172000029x

  • The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    The Lancet Psychiatry · 2019 · https://doi.org/10.1016/s2215-0366(19)30048-3

  • Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

    World Psychiatry · 2019 · 10.1002/wps.20629

  • The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    The Lancet Psychiatry · 2019 · https://doi.org/10.1016/s2215-0366(19)30048-3

  • White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

    Frontiers in Psychiatry · 2019 · 10.3389/fpsyt.2019.00676

  • Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia

    Schizophrenia Bulletin · 2018 · 10.1093/schbul/sby050

  • Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry · 2018 · 10.1016/s2215-0366(18)30252-9

  • Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study

    JAMA Psychiatry · 2017 · 10.1001/jamapsychiatry.2017.3554

  • International trends in antipsychotic use: A study in 16 countries, 2005–2014

    European Neuropsychopharmacology · 2017 · 10.1016/j.euroneuro.2017.07.001

  • International trends in clozapine use: a study in 17 countries

    Acta Psychiatrica Scandinavica · 2017 · https://doi.org/10.1111/acps.12742

  • Assessment and management of agitation in psychiatry: Expert consensus

    The World Journal of Biological Psychiatry · 2016 · https://doi.org/10.3109/15622975.2015.1132007

  • The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study

    European Neuropsychopharmacology · 2016 · 10.1016/j.euroneuro.2016.07.003

  • Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis

    Schizophrenia Research · 2016 · 10.1016/j.schres.2016.09.026

  • Inflammation in schizophrenia: A question of balance

    Neuroscience & Biobehavioral Reviews · 2015 · 10.1016/j.neubiorev.2015.05.014

  • Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study

    Schizophrenia Research · 2015 · 10.1016/j.schres.2015.02.022

  • Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia

    Schizophrenia Bulletin · 2013 · 10.1093/schbul/sbt001

  • Brain Effects of Cognitive Remediation Therapy in Schizophrenia: A Structural and Functional Neuroimaging Study

    Biological Psychiatry · 2013 · 10.1016/j.biopsych.2013.01.017

  • Metabolic profile of antipsychotic-naive individuals with non-affective psychosis

    The British Journal of Psychiatry · 2009 · 10.1192/bjp.bp.108.052605

  • Standardized remission criteria in schizophrenia

    Acta Psychiatrica Scandinavica · 2005 · 10.1111/j.1600-0447.2005.00659.x

  • Decreased cerebral activation during CPT performance

    NeuroImage · 2004 · 10.1016/j.neuroimage.2003.10.027

  • Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients

    NeuroImage · 2003 · 10.1016/s1053-8119(03)00094-6

  • Paracingulate sulcus morphology in men with early-onset schizophrenia

    The British Journal of Psychiatry · 2003 · 10.1192/bjp.182.3.228

  • Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia

    American Journal of Psychiatry · 2001 · 10.1176/appi.ajp.158.7.1149

  • Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease.

    PubMed · 1994

Current projects

    No projects listed.